EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone‐Related Diseases

Xuemei Long iD, Dan Tan iD, Qianke Tao, Qiaonan Ye iD, Luwen Ye, Qing Li, Jingang Xiao iD

Cell Proliferation · 2026-04 · 59 (4)

DOI: 10.1111/cpr.70178 ↗

At a glance

Übersichtsarbeit in Cell Proliferation, published online on 2026-02-03. Written by Xuemei Long and 6 co-authors. Institution: Department of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China. Major MEDLINE topics: Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Bone Diseases, Bone Marrow Cells. Cited 6 times so far (Crossref); 291 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, Open Project of State Key Laboratory of Oral Diseases.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Bone‐related diseases (e.g., osteoporosis, osteoarthritis and fractures) exhibit a rising global incidence, imposing significant burdens on both quality of life and healthcare systems. Conventional therapeutic approaches, including anti‐resorptive drugs and surgical interventions, face limitations such as long‐term medication requirements, adverse effects (e.g., bisphosphonate‐related osteonecrosis of the jaw) and suboptimal efficacy. Bone marrow mesenchymal stromal cells (BMSCs) have emerged as a promising therapeutic alternative due to their accessibility, multi‐lineage differentiation potential, immunomodulatory properties and homing capacity. However, challenges such as disease complexity, mechanistic heterogeneity and therapeutic inconsistency hinder their clinical translation. Recent advances in genetic engineering, preconditioning strategies, bone tissue engineering (e.g., three‐dimensional [3D] scaffolding), extracellular vesicle‐based therapies and epigenetic regulation (e.g., histone modification) have significantly enhanced the therapeutic effects of BMSCs. Furthermore, cutting‐edge technologies like organoids and 3D bioprinting, which stem from advances in tissue engineering, offer novel avenues for clinical applications. Given these rapid developments, this review systematically summarises BMSC‐based treatment strategies for bone‐related diseases, discusses current challenges and outlines future directions to advance translational research.

Subjects

MeSH terms (MEDLINE)

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationBone DiseasesBone Marrow CellsHumansAnimalsTissue EngineeringCell Differentiation

Author keywords

bone marrow mesenchymal stromal cells (BMSCs)bone‐related diseasesosteogenic differentiationtherapeutic strategies

Authors and institutions

  • Department of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
  • Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
  • Department of Periodontal and Mucosal Diseases, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
  • Department of Plastic and Burn Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Department of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.

ORCID profiles: Xuemei Long, Dan Tan, Qiaonan Ye, Jingang Xiao

Funding

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province
  • Open Project of State Key Laboratory of Oral Diseases
  • Science and Technology Project of Health Commission of Sichuan Province
  • Scientific and Technological Project of Luzhou
  • The Youth Innovation Project of Sichuan Medical Association
  • 2023 Key Project of The Affiliated Stomatological Hospital of Southwest Medical University
  • The 2025 Doctoral Research Initiation Project of the Affiliated Stomatological Hospital of Southwest Medical University

Cite

APA

Long, X., Tan, D., Tao, Q., Ye, Q., Ye, L., Li, Q., & Xiao, J. (2026). Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone‐Related Diseases. Cell Proliferation, 59(4). https://doi.org/10.1111/cpr.70178

Vancouver

Long X, Tan D, Tao Q, Ye Q, Ye L, Li Q, et al. Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone‐Related Diseases. Cell Proliferation. 2026;59(4). doi:10.1111/cpr.70178

BibTeX
@article{Long2026,
  author = {Long, Xuemei and Tan, Dan and Tao, Qianke and Ye, Qiaonan and Ye, Luwen and Li, Qing and Xiao, Jingang},
  title = {Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone‐Related Diseases},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {4},
  doi = {10.1111/cpr.70178}
}
Start for free →